Insider · CIK 0001804460

Paulson Richard A.

Reports to the SEC for 2 companies · NEWTON, MA

sec.gov

Transactions

Companies

Filings

CIK

0001804460

Forms 4 and 5

Insider transactions

50 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2026-05-14	KPTIKaryopharm Therapeutics Inc.S Sale	Director, President and CEO	SSale	−2,203 sh	$9.50	−$20.9K	269,747
2026-05-13	KPTIKaryopharm Therapeutics Inc.A Award	Director, President and CEO	AAward	+4,920 sh	—	—	271,950
2026-03-02	KPTIKaryopharm Therapeutics Inc.S Sale	Director, President and CEO	SSale	−12.4K sh	$9.41	−$116K	267,030
2026-02-05	KPTIKaryopharm Therapeutics Inc.A Award	Director, President and CEO	AAward	+81.1K sh	—	—	279,391
2025-10-15	KPTIKaryopharm Therapeutics Inc.A Award	Director, President and CEO	AAward	+114K sh	—	—	198,331
2025-09-15	KPTIKaryopharm Therapeutics Inc.S Sale	Director, President and CEO	SSale	−1,257 sh	$6.43	−$8,082.51	84,046
2025-09-12	KPTIKaryopharm Therapeutics Inc.A Award	Director, President and CEO	AAward	+2,800 sh	—	—	85,303
2025-06-02	bluebird bio, Inc.D Disposition to Issuer	Director	DDisposition to Issuer	−1,323 sh	—	—	0
2025-05-30	bluebird bio, Inc.U Disposition from Tender	Director	UDisposition from Tender	−155 sh	—	—	1,323
2025-05-06	KPTIKaryopharm Therapeutics Inc.S Sale	Director, President and CEO	SSale	−236 sh	$7.12	−$1,680.32	82,503
2025-04-04	KPTIKaryopharm Therapeutics Inc.S Sale	Director, President and CEO	SSale	−245 sh	$3.74	−$916.3	82,739
2025-03-04	KPTIKaryopharm Therapeutics Inc.S Sale	Director, President and CEO	SSale	−11.7K sh	$6.29	−$73.6K	82,984
2025-02-28	KPTIKaryopharm Therapeutics Inc.A Award	Director, President and CEO	AAward	+20K sh	—	—	94,678
2025-02-28	KPTIKaryopharm Therapeutics Inc. · Stock Option (right to buy)A Award	Director, President and CEO	AAward	+40K sh	—	—	40,000
2025-02-04	KPTIKaryopharm Therapeutics Inc.S Sale	Director, President and CEO	SSale	−4,099 sh	$0.65	−$2,664.35	1,120,158
2025-01-06	KPTIKaryopharm Therapeutics Inc.S Sale	Director, President and CEO	SSale	−4,055 sh	$0.78	−$3,175.065	1,124,257
2024-12-04	KPTIKaryopharm Therapeutics Inc.S Sale	Director, President and CEO	SSale	−3,620 sh	$0.81	−$2,932.2	1,128,312
2024-11-06	bluebird bio, Inc.A Award	Director	AAward	+24.9K sh	—	—	29,563
2024-11-06	bluebird bio, Inc.Stock Option (right to buy)A Award	Director	AAward	+49.9K sh	—	—	49,850
2024-11-05	KPTIKaryopharm Therapeutics Inc.S Sale	Director, President and CEO	SSale	−3,675 sh	$0.91	−$3,346.455	1,131,932
2024-10-04	KPTIKaryopharm Therapeutics Inc.S Sale	Director, President and CEO	SSale	−3,607 sh	$0.88	−$3,171.635	1,135,607
2024-09-04	KPTIKaryopharm Therapeutics Inc.S Sale	Director, President and CEO	SSale	−3,667 sh	$0.72	−$2,646.841	1,139,214
2024-08-06	KPTIKaryopharm Therapeutics Inc.S Sale	Director, President and CEO	SSale	−3,608 sh	$0.93	−$3,355.079	1,142,881
2024-07-05	KPTIKaryopharm Therapeutics Inc.S Sale	Director, President and CEO	SSale	−3,616 sh	$0.85	−$3,077.216	1,146,489
2024-06-04	KPTIKaryopharm Therapeutics Inc.S Sale	Director, President and CEO	SSale	−3,592 sh	$0.99	−$3,556.08	1,150,105
2024-05-06	KPTIKaryopharm Therapeutics Inc.S Sale	Director, President and CEO	SSale	−3,576 sh	$1.13	−$4,040.88	1,153,697
2024-04-04	KPTIKaryopharm Therapeutics Inc.S Sale	Director, President and CEO	SSale	−3,563 sh	$1.29	−$4,596.27	1,157,273
2024-03-05	KPTIKaryopharm Therapeutics Inc.S Sale	Director, President and CEO	SSale	−3,573 sh	$1.30	−$4,644.9	1,160,836
2024-03-01	KPTIKaryopharm Therapeutics Inc.S Sale	Director, President and CEO	SSale	−19.4K sh	$1.20	−$23.2K	1,164,409
2024-02-29	KPTIKaryopharm Therapeutics Inc.S Sale	Director, President and CEO	SSale	−80.5K sh	$1.17	−$94.1K	1,183,783
2024-02-28	KPTIKaryopharm Therapeutics Inc.A Award	Director, President and CEO	AAward	+443K sh	—	—	1,264,253
2024-02-06	KPTIKaryopharm Therapeutics Inc.S Sale	Director, President and CEO	SSale	−4,012 sh	$1.59	−$6,365.038	821,453
2024-01-24	KPTIKaryopharm Therapeutics Inc.A Award	Director, President and CEO	AAward	+42K sh	—	—	825,465
2024-01-04	KPTIKaryopharm Therapeutics Inc.S Sale	Director, President and CEO	SSale	−4,114 sh	$0.82	−$3,373.48	783,465
2023-12-04	KPTIKaryopharm Therapeutics Inc.S Sale	Director, President and CEO	SSale	−3,622 sh	$0.79	−$2,861.38	787,579
2023-11-06	KPTIKaryopharm Therapeutics Inc.S Sale	Director, President and CEO	SSale	−3,606 sh	$0.92	−$3,318.602	791,201
2023-10-04	KPTIKaryopharm Therapeutics Inc.S Sale	Director, President and CEO	SSale	−3,589 sh	$1.27	−$4,558.03	794,807
2023-09-05	KPTIKaryopharm Therapeutics Inc.S Sale	Director, President and CEO	SSale	−3,558 sh	$1.33	−$4,732.14	798,460
2023-09-05	KPTIKaryopharm Therapeutics Inc.S Sale	Director, President and CEO	SSale	−64 sh	$1.32	−$84.48	798,396
2023-08-07	KPTIKaryopharm Therapeutics Inc.S Sale	Director, President and CEO	SSale	−3,722 sh	$1.72	−$6,401.84	802,018
2023-07-05	KPTIKaryopharm Therapeutics Inc.S Sale	Director, President and CEO	SSale	−3,538 sh	$1.72	−$6,085.36	805,740
2023-06-05	KPTIKaryopharm Therapeutics Inc.S Sale	Director, President and CEO	SSale	−3,536 sh	$2.24	−$7,922.054	809,278
2023-05-04	KPTIKaryopharm Therapeutics Inc.S Sale	Director, President and CEO	SSale	−3,805 sh	$3.35	−$12.8K	812,814
2023-04-04	KPTIKaryopharm Therapeutics Inc.S Sale	Director, President and CEO	SSale	−3,497 sh	$3.97	−$13.9K	816,619
2023-04-03	bluebird bio, Inc.A Award	Director	AAward	+4,663 sh	—	—	4,663
2023-04-03	bluebird bio, Inc.Stock Options (Right to buy)A Award	Director	AAward	+7,500 sh	—	—	7,500
2023-03-06	KPTIKaryopharm Therapeutics Inc.S Sale	Director, President and CEO	SSale	−3,506 sh	$3.16	−$11.1K	820,116
2023-03-01	KPTIKaryopharm Therapeutics Inc.S Sale	Director, President and CEO	SSale	−33K sh	$3.03	−$100K	823,622
2023-02-28	KPTIKaryopharm Therapeutics Inc.A Award	Director, President and CEO	AAward	+252K sh	—	—	856,655
2023-02-06	KPTIKaryopharm Therapeutics Inc.S Sale	Director, President and CEO	SSale	−3,950 sh	$3.40	−$13.4K	604,655

Recent filings

Accepted (ET)
May 154
Paulson Richard A.0001193125-26-226613
SEC(opens sec.gov)
Mar 34
Paulson Richard A.0001804460-26-000003
SEC(opens sec.gov)
Feb 94
Paulson Richard A.0001193125-26-042799
SEC(opens sec.gov)
Oct 164
Paulson Richard A.0001193125-25-241471
SEC(opens sec.gov)
Sep 164
Paulson Richard A.0001193125-25-205052
SEC(opens sec.gov)
Jun 34
Paulson Richard A.0000950170-25-081108
SEC(opens sec.gov)
May 74
Paulson Richard A.0000950170-25-065884
SEC(opens sec.gov)
Apr 74
Paulson Richard A.0000950170-25-051658
SEC(opens sec.gov)
Mar 64
Paulson Richard A.0000950170-25-034736
SEC(opens sec.gov)
Mar 44
Paulson Richard A.0000950170-25-032297
SEC(opens sec.gov)
Feb 54
Paulson Richard A.0000950170-25-014491
SEC(opens sec.gov)
Jan 74
Paulson Richard A.0000950170-25-002819
SEC(opens sec.gov)
Dec 54
Paulson Richard A.0000950170-24-133689
SEC(opens sec.gov)
Nov 84
Paulson Richard A.0001562180-24-007607
SEC(opens sec.gov)
Nov 64
Paulson Richard A.0000950170-24-122274
SEC(opens sec.gov)

Companies

Address

C/O KARYOPHARM THERAPEUTICS INC. 85 WELLS AVENUE

NEWTON, MA, 02459